In fact, the level of S100A11 in the synovial fluid of cyclic citrullinated peptide-positive patients has been observed to be significantly higher than that in cyclic citrullinated peptide-negative patients [41], which further supports the notion that S100A11 participates in the local inflammatory process of RA. Here, S100A11 is linked to rheumatoid arthritis.